Corporate News
Medical laboratory accreditation for COVID testing
01 September 2021
ISO 15189:2012 accreditation confirms internationally recognised gold standard for MHC lab testing
MyHealthChecked
Plc (AIM: MHC), the consumer home-testing healthcare
company, announces that it now has ISO 15189:2012
accreditation across the Company's COVID-19 testing service, a mark
of confidence that the service meets internationally recognised gold
standards for performance and competence.
The accreditation was granted following assessments
by the United Kingdon Accreditation Service ("UKAS"), and
ensures that the laboratories used as part of
the MyHealthChecked™ COVID-19 testing service deliver a
proficient and high-quality service, meeting the relevant legal
requirements.
The MyHealthChecked™ COVID-19 at-home nasal swab kit and PCR
laboratory testing service utilises the Company's own laboratory in
Manchester, together with its partner laboratory provided by Yourgene
Health plc, which also has received ISO 15189:2012 accreditation
for testing and sequencing.
MyHealthChecked's services have been included as one of the suppliers on
the Government list with "Fit to Fly", "Test to Release" and "Days 2 and
8" testing, and the Company has established a key commercial partnership
with Boots UK Limited ("Boots"). The MyHealthChecked COVID-19
testing service is available via www.boots.com and across over
500 Boots stores in Great Britain.
Penny McCormick, Chief Executive Officer of MyHealthChecked Plc, said:
"We are delighted to now have in place accreditation across our
COVID-19 testing service, which is a clear sign to our existing
customers and potential new customers that our medical laboratories
and operational systems are extremely rigorous and structured around
best possible practice within the industry.
"I am incredibly proud of the MyHealthChecked team for maintaining these high standards, ensuring that we offer a reliable and efficient service to all of our partners."
The persons responsible for arranging the release of this Announcement on behalf of the Company are Penny McCormick, CEO, and Gareth Davies, Chief Financial and Operations Officer respectively.
For further information contact:
MyHealthChecked plc |
||
Penny McCormick, Chief Executive Officer |
via Walbrook PR |
|
Gareth Davies, Chief Financial and Operations Officer |
|
|
|
|
|
SPARK Advisory Partners Limited (NOMAD) |
Tel: +44 (0)20 3368 3550 |
|
Neil Baldwin |
|
|
|
|
|
Oberon Capital Ltd (Broker) |
Tel: +44 (0)203 179 5344 |
|
Mike Seabrook |
mikeseabrook@oberoninvestments.com |
|
|
|
|
Walbrook PR Ltd (Media & IR) |
Tel: +44 (0)20 7933 8780 |
|
Paul McManus / Alice Woodings |
Mob: +44(0)7980 541 893 / +44 (0)7407 804 654 |
|
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK
healthcare company focused on a range of at-home healthcare and wellness
tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and
RNA tests, now in development following the acquisition of The Genome
Store in November 2020. The tests will be made available online, and
would be viable for over the counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in
mindset as customers become more familiar with the concept of accessible
healthcare in the growing at home testing kit market with a focus on
accessibility at the right price, led by UK-based experts.
About UKAS - The United Kingdom Accreditation Service is the national accreditation body for the United Kingdom, appointed by government, to assess organisations that provide certification, testing, inspection and calibration services. UKAS has been working with the Department for Health and Social Care to develop a three stage UKAS accreditation process for private providers of COVID-19 testing. This scheme has been used for any providers of private COVID-19 testing requiring accreditation for their services.